Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for Patients With Recurrent IDH-mutant Astrocytoma or Oligodendroglioma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating L19TNF with alkylating chemotherapy for recurrent IDH-mutant astrocytoma or IDH-mutant oligodendroglioma; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idh-mutant Astrocytoma
• Idh-mutant Oligodendroglioma

Drugs mentioned

• L19TNF

Snippet

Sponsor: Philogen S.p.A. | Conditions: Glioma | Phase 2 | Status: NOT_YET_RECRUITING